Order Article Reprints

Xu M-Y, Zhang J-B, Peng Y-Z, Liu M-C, Ma S-Y, Zhou Y, Wang Z-H, Ma S. Network Pharmacology and Experimental Validation Identify Paeoniflorin as a Novel SRC-Targeted Therapy for Castration-Resistant Prostate Cancer. Pharmaceuticals. 2025; 18(8):1241. https://doi.org/10.3390/ph18081241

Xu, Meng-Yao, Jun-Biao Zhang, Yu-Zheng Peng, Mei-Cheng Liu, Si-Yang Ma, Ye Zhou, Zhi-Hua Wang, and Sheng Ma. 2025. "Network Pharmacology and Experimental Validation Identify Paeoniflorin as a Novel SRC-Targeted Therapy for Castration-Resistant Prostate Cancer" Pharmaceuticals 18, no. 8: 1241. https://doi.org/10.3390/ph18081241

Xu, M.-Y., Zhang, J.-B., Peng, Y.-Z., Liu, M.-C., Ma, S.-Y., Zhou, Y., Wang, Z.-H., & Ma, S. (2025). Network Pharmacology and Experimental Validation Identify Paeoniflorin as a Novel SRC-Targeted Therapy for Castration-Resistant Prostate Cancer. Pharmaceuticals, 18(8), 1241. https://doi.org/10.3390/ph18081241